secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001213900-26-024726
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies raises $2M via 10% OID convertible notes and warrants; $2.2M principal
--------------------------------------------------------------------------------

- Gross proceeds $2M; notes carry 4% interest, mature March 4, 2027.
- Warrants to purchase up to 1,666,667 shares at $1.40, 5-year term; 100% warrant coverage.
- Conversion: mandatory upon qualified offering ≥$2.5M; voluntary at 90% of 10-day VWAP.
- Proceeds to fund clinical trials, R&D, and working capital.
- 19.99% issuance cap without stockholder approval; resale registration to be filed within 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026024726/0001213900-26-024726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026024726/ea0280014-8k_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-024726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer